deaths (OS)progression or deaths (PFS)RFS/DFS

mML - NA - all population metastatic/adv melanoma (mML) mML - (neo)adjuvant (NA) mML - NA - all population

versus Ipilimumab (10 mg/kg)
nivolumab alone vs. Ipilimumab (10 mg/kg) 1 certainty unassessable-12%- certainty unassessablestatistically conclusive-32%
versus placebo
nivolumab alone vs. placebo 1 -- certainty unassessablestatistically conclusive-40%